Trends in adverse drug reaction reporting by dentists: a 15-year analysis of German pharmacovigilance data
Clinical Oral Investigations · 27.04.2026 · 30 (5)
DOI: 10.1007/s00784-026-06889-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oral Investigations, online erschienen am 27.04.2026. Verfasst von Frank Halling und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Craniomaxillofacial Surgery, UKGM GmbH, University Hospital Marburg and Faculty of Medicine, Philipps University, 35043, Marbu…. Hauptthemen laut MEDLINE: Pharmacovigilance, Adverse Drug Reaction Reporting Systems, Drug-Related Side Effects and Adverse Reactions, Dentists. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Philipps-Universität Marburg.
Abstract (Originalsprache)
Objectives
Dentists frequently encounter adverse drug reactions (ADRs) in their day-to-day work. Despite the legal obligation in Germany to report ADRs, systematic evaluations of dental pharmacovigilance data remain scarce. This study aimed to analyze ADR reports submitted by dentists to the Drug Commission of the German Dental Association. Materials and methods All ADR reports submitted between 2010 and 2024 were analyzed according to year, medication class, and affected organ system. Incidence rates per dentist were calculated and trends over time were assessed using Poisson regression analysis.
Results
A total of 983 ADR reports were included. Antibiotics accounted for the majority of reports (59.4%), followed by local anesthetics (15.7%). The most frequently affected organ systems were the skin (39.8%) and the gastrointestinal tract (21.7%). On average, 65.5 reports were submitted annually. The overall incidence rate was 91.7 reports per 100,000 dentist years, declining by 9.5% annually over the study period. Clindamycin had the highest incidence of ADR reports (26.7 per 100,000 dentist years) but also the steepest annual decrease (–17.1% per year).
Conclusion
The proportion of ADRs reported by dentists is low compared with the expected number of ADRs, indicating substantial underreporting. A significant decline in reporting was observed over time. Consistent with previous studies, antibiotics and cutaneous reactions predominated. The reduction in clindamycin-related ADR reports reflects a substantial decrease in clindamycin prescriptions in Germany. Clinical relevance Mandatory spontaneous reporting remains essential for dental pharmacovigilance. However, implementing digital tools and low-threshold reporting systems could improve the quantity and quality of future ADR reports.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Craniomaxillofacial Surgery, UKGM GmbH, University Hospital Marburg and Faculty of Medicine, Philipps University, 35043, Marburg, Germany.
- Department of Oral and Craniomaxillofacial Surgery, UKGM GmbH, University Hospital Marburg and Faculty of Medicine, Philipps University, 35043, Marburg, Germany. axel.meisgeier@med.uni-marburg.de.
Förderung
- Philipps-Universität Marburg
Zitieren
APA
Halling, F., Lutz, R., & Meisgeier, A. (2026). Trends in adverse drug reaction reporting by dentists: a 15-year analysis of German pharmacovigilance data. Clinical Oral Investigations, 30(5). https://doi.org/10.1007/s00784-026-06889-6
Vancouver
Halling F, Lutz R, Meisgeier A. Trends in adverse drug reaction reporting by dentists: a 15-year analysis of German pharmacovigilance data. Clinical Oral Investigations. 2026;30(5). doi:10.1007/s00784-026-06889-6
BibTeX
@article{Halling2026,
author = {Halling, Frank and Lutz, Rainer and Meisgeier, Axel},
title = {Trends in adverse drug reaction reporting by dentists: a 15-year analysis of German pharmacovigilance data},
journal = {Clinical Oral Investigations},
year = {2026},
volume = {30},
number = {5},
doi = {10.1007/s00784-026-06889-6}
}
EUVIMED